Tuesday 24 December 2024

The Pharma Letter Podcast — Episode 11 — Should US states control drug prices?

Biotechnology
Simon Wentworth
4 March 2022
episode11-big

More on this story...

Pharmaceutical
The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?
10 February 2022
Biotechnology
The Pharma Letter Podcast — Episode 9 — The rise of AI in drug discovery
30 December 2021
Biotechnology
The Pharma Letter Podcast — Episode 8 — Why hasn't the world embraced Sputnik V?
14 December 2021
Pharmaceutical
Will the unintended consequences of drug price transparency regulation outweigh its benefits?
18 March 2022


More ones to watch >


Today's issue

AstraZeneca withdraws EU submission for lung cancer drug
Biotechnology
AstraZeneca withdraws EU submission for lung cancer drug
24 December 2024
Biotechnology
Valneva links up with SII for chikungunya vaccine in Asia
24 December 2024
Generics
Viatris faces FDA import restrictions at Indian facility
24 December 2024
Pharmaceutical
Aficamten attracts more interest as Sanofi buys China rights
24 December 2024
Biotechnology
Positive Phase III trials results with BMS’ Sotyktu
24 December 2024
Generics
FDA approves first generic of Victoza
24 December 2024
Pharmaceutical
Sumitomo gains FDA approval of Gemtesa for OAB
24 December 2024

Company Spotlight

A clinical-stage immuno-oncology company from Switzerland.




More Features in Biotechnology

AstraZeneca withdraws EU submission for lung cancer drug
24 December 2024
Valneva links up with SII for chikungunya vaccine in Asia
24 December 2024
Positive Phase III trials results with BMS’ Sotyktu
24 December 2024
RAPT obtains worldwide rights ex-China to Jemincare MAb
24 December 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze